In a variant form of castration-resistant prostate cancer, galeterone shows activity
11/21/2014
Results from a trial of the anti-cancer drug galeterone show that it is successful in lowering prostate-specific antigen (PSA) levels in men with a form of prostate cancer that is resistant to...
Three drugs may be better than one for certain patients with advanced colorectal cancer
11/21/2014
Patients with a form of advanced colorectal cancer that is driven by a mutated version of the BRAF gene have limited treatment options available.
Ferroptosis, a novel form of non-apoptotic cell death, holds great therapeutic potential
11/21/2014
Ferroptosis is a newly discovered form of cell death believed to be involved in numerous pathological processes.
A combination of 2 existing anti-cancer drugs for kidney cancer shows good patient response
11/21/2014
Researchers have found that patients with an advanced form of kidney cancer, for which there is no standard treatment and a very poor prognosis, respond well to a combination of two existing...
Designing medications like chemotherapy with fewer side effects, using new computational model
11/21/2014
Medications, such as chemotherapy, are often limited by their tendency to be detrimental to healthy cells as an unintended side effect.
The Great American Smokeout: a great day to quit smoking
11/20/2014
Have you been thinking of giving up the habit? The Great American Smokeout is an annual event that encourages the nation to quit smoking, whether it is for 1 day or for good.
A new drug that targets not only common cancer-causing genetic mutations in patients with non-small cell lung cancer (NSCLC), but also a form of the mutation that causes resistance to treatment...
Most Americans don't get the daily recommended amount of fiber in their diet
11/20/2014
Most Americans don't get the daily recommended amount of fiber in their diet, though research has shown that dietary fiber can cause a shift in the gut toward beneficial bacteria, reducing the risk...
Health Canada approves IMBRUVICA for chronic lymphocytic leukemia
11/20/2014
Janssen Inc. has announced Health Canada has approved IMBRUVICA (ibrutinib) for the treatment of the blood cancer chronic lymphocytic leukemia (CLL).
Surgery plus chemoradiation linked to improved survival rates for gastric cancer patients
11/20/2014
Patients who receive chemotherapy and radiation after surgery for gastric cancer appear to have better survival rates than those who had surgery followed by only chemotherapy, according to results...